Growth Metrics

AtriCure (ATRC) Capital Expenditures (2016 - 2025)

AtriCure (ATRC) has disclosed Capital Expenditures for 16 consecutive years, with -$6.2 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures fell 627.76% to -$6.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 277.84% year-over-year, with the annual reading at $1.3 million for FY2025, 277.84% up from the prior year.
  • Capital Expenditures for Q4 2025 was -$6.2 million at AtriCure, down from $2.6 million in the prior quarter.
  • The five-year high for Capital Expenditures was $15.0 million in Q4 2022, with the low at -$6.2 million in Q4 2025.
  • Average Capital Expenditures over 5 years is $1.6 million, with a median of $1.8 million recorded in 2024.
  • Peak annual rise in Capital Expenditures hit 1481.82% in 2022, while the deepest fall reached 7435.06% in 2022.
  • Over 5 years, Capital Expenditures stood at $946000.0 in 2021, then soared by 1481.82% to $15.0 million in 2022, then tumbled by 81.38% to $2.8 million in 2023, then tumbled by 130.51% to -$850000.0 in 2024, then plummeted by 627.76% to -$6.2 million in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at -$6.2 million, $2.6 million, and $3.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.